LeMaitre Vascular
LMAT
297 hedge funds and large institutions have $1.73B invested in LeMaitre Vascular in 2025 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 108 increasing their positions, 114 reducing their positions, and 26 closing their positions.
15% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 26
1.26% more ownership
Funds ownership: 92.67% → 93.93% (+1.3%)
0% more funds holding
Funds holding: 297 → 297 (0)
5% less repeat investments, than reductions
Existing positions increased: 108 | Existing positions reduced: 114
6% less capital invested
Capital invested by funds: $1.84B → $1.73B (-$107M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $219K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$19.9M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$9.57M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.12M |
| 4 |
Two Sigma Investments
New York
|
+$6.87M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$6.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$20.5M |
| 2 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$12.9M |
| 3 |
Rockefeller Capital Management
New York
|
-$8.69M |
| 4 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
-$8.4M |
| 5 |
CCM
Copeland Capital Management
Conshohocken,
Pennsylvania
|
-$4.42M |
LMAT Hedge Fund Activity: Q4 2025 in Review
297 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q4 2025, worth a combined $1.73B — down 5.9% from $1.84B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new LMAT positions and 26 closed out — a net gain of 4 holders — while 108 added to existing stakes and 114 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $19.9M. The largest seller was T. Rowe Price Associates, cutting an estimated $20.5M.
- 297 institutional investors held LeMaitre Vascular (LMAT) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $1.73B of LeMaitre Vascular stock for Q4 2025, down 5.9% quarter-over-quarter.
- 30 funds opened new LeMaitre Vascular positions in Q4 2025 and 26 closed out, a net change of +4 holders.
- The largest LeMaitre Vascular buyer in Q4 2025 was Goldman Sachs, an estimated $19.9M added.
- The largest LeMaitre Vascular seller in Q4 2025 was T. Rowe Price Associates, an estimated $20.5M sold.
Based on aggregated 13F filings for Q4 2025.